The European Union's medicines watchdog says it has moved forward the date for a decision on authorizing Moderna's coronavirus vaccine to next year January 6 from January 12.

The Amsterdam-based European Medicines Agency says US-based Moderna has sent extra data ahead of schedule, so the regulator has "scheduled an extraordinary meeting on 6 January 2021 to conclude its assessment, if possible".